Atlas market file · Etf · United States
AllianzIM U.S. Equity Buffer15 Uncapped Dec ETFDECU
- Last close
- 29.998
- Change
- +0.55%
- 96-bar range
- 26.13 – 30.095
- As of
- 7 Aug 2026
AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF is an exchange-traded fund listed as DECU on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 89 weekly closes (+19.11% over the window).
Source rail: Yahoo Finance chart API (DECU). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for DECU. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
DECU public profile
Exchange-traded fund. AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF is connected to current market context, cited company sources and its retained research file.
AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF trades as DECU on BATS. AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) has a latest verified close of 29.998, up 0.55%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. DECU stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF today
DECU, the AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF, entered public trading with a mandate that sounds like a hedge-fund daydream and a fee structure that reads like a banker’s invoice. The fund promises a fifteen-percent buffer against equity losses, but only within a narrow window tied to the Russell 2000’s December expiration, turning what sounds like a market miracle into a seasonal carnival act that resets every year. The SEC’s EDGAR filing for DECU confirms the fund’s existence and legal skeleton, but the document is silent on holdings, which means the source requires readers to trust the wrapper without seeing the bones underneath.
The issuer’s marketing sells the idea of capped pain and uncapped gain, but the FINRA fund analyzer spells out the true cost: a 0.79% expense ratio that chips away at any buffer before the market has a chance to prove itself. The fund’s structure is a buffered outcome tied to a single calendar event, not a perpetual shield, which turns a once-a-year reset into the main event rather than a footnote. The Nasdaq ticker page confirms the fund trades, but offers no insight into liquidity depth or the identity of the basket it tracks.
The SEC filing lists DECU as a buffered outcome ETF referencing the Russell 2000, a small-cap index where fortunes swing on sentiment as much as fundamentals. The filing does not disclose top holdings or concentration limits, leaving investors to wonder which thirty or forty small-cap stocks are underwriting the buffer. The mandate’s December linkage means the fund’s performance is a function of both the index’s path and the calendar’s cruel timing, not the fund’s skill at stock-picking. The only certainty is that AllianzIM earns its fee regardless of how the year ends.
The Nasdaq page for DECU shows the ticker is live, but the data on spreads, volume, and intraday liquidity is either absent or stale. The fund’s existence is proven; its daily liquidity and fair-value mechanics are not. The FINRA analyzer confirms the fee but cannot reveal how the buffer behaves in stress because the mechanism is locked to a single December reset. The fund’s structure is a legal time capsule that opens on a fixed date, not a dynamic toolkit for investors to deploy.
What remains unproven is whether DECU’s fifteen-percent buffer is worth the 0.79% annual vig, especially when the Russell 2000’s volatility can shred the benefit in a single bad quarter. The fund’s marketing is glossy; the rules are rigid; the holdings are a mystery. Until the SEC filing or issuer updates disclose the basket or the fund’s performance in varied markets, DECU remains a ticker in search of a story.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
DECU technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on DECU
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep DECU research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
DECU FAQ
What is AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU)?AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) has a latest verified close of 29.998, up 0.55%, dated 7 Aug 2026. Use this page to check the price chart,...
AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) has a latest verified close of 29.998, up 0.55%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for DECU?AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) has a latest verified close of 29.998, up 0.55%, dated 7 Aug 2026. It brings the latest available chart, company...
AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) has a latest verified close of 29.998, up 0.55%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. DECU stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the DECU page updated?The DECU public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The DECU public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for DECU?The DECU file starts with Nasdaq Trader and TradingView BATS:DECU. The page separates verified market context from company evidence and shows open evidence gaps instead...
The DECU file starts with Nasdaq Trader and TradingView BATS:DECU. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on DECU?Yes. The workstation can open DECU, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open DECU, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this DECU page investment advice?No. The DECU page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The DECU page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
DECU
Etf · evidence first